Li Jin, Yuan Fang, Fan Shengfu, Tian Jie, Yang Jianzhou
Institute of Health and Quarantine, Science and Technology Research Center of China Customs, Beijing, China; Department of Public Health and Preventive Medicine, Changzhi Medical College, Changzhi, China.
Institute of Health and Quarantine, Science and Technology Research Center of China Customs, Beijing, China.
Am J Infect Control. 2025 Mar;53(3):340-347. doi: 10.1016/j.ajic.2024.10.010. Epub 2024 Oct 23.
During major public health crises, the epidemiological characteristics of commonly reported infectious diseases may change. Based on routinely reported data on notifiable infectious diseases, we investigated whether the incidence and mortality of infectious diseases in China were affected by the coronavirus disease (COVID-19).
We analyzed monthly reported data on nationally notifiable infectious diseases from January 2013 to March 2024. Using an interrupted time series design, we performed Poisson regression to assess changes in the incidence and mortality rates of infectious diseases before, during, and after the COVID-19 pandemic.
We found that during the COVID-19 outbreak, the reported incidence of nationally notifiable infectious diseases significantly and immediately decreased (relative risk [RR]= 0.6206; 95% confidence interval [CI]= 0.6201-0.6211), and so did the mortality rate (RR=0.7814; 95% CI=0.7696-0.7933). After the end of pandemic control measures, the reported incidence surged abruptly starting from January 2023, showing a sharp rise compared with the prepandemic period (RR=1.8608; 95% CI=1.8595-1.8621). The reported mortality increased, too (RR=1.081; 95% CI=1.0638-1.0984).
The overall incidence and mortality of infectious diseases decreased immediately after the outbreak of COVID-19. After the end of pandemic control measures, their incidence rate sharply increased, and their mortality rate also rose.
在重大公共卫生危机期间,常见报告传染病的流行病学特征可能会发生变化。基于法定传染病的常规报告数据,我们调查了中国传染病的发病率和死亡率是否受到冠状病毒病(COVID-19)的影响。
我们分析了2013年1月至2024年3月全国法定传染病的月度报告数据。采用中断时间序列设计,我们进行了泊松回归,以评估COVID-19大流行之前、期间和之后传染病发病率和死亡率的变化。
我们发现,在COVID-19疫情期间,全国法定传染病的报告发病率显著且立即下降(相对风险[RR]=0.6206;95%置信区间[CI]=0.6201-0.6211),死亡率也下降(RR=0.7814;95%CI=0.7696-0.7933)。在大流行控制措施结束后,报告发病率从2023年1月开始突然激增,与大流行前时期相比大幅上升(RR=1.8608;95%CI=1.8595-1.8621)。报告死亡率也有所上升(RR=1.081;95%CI=1.0638-1.0984)。
COVID-19疫情爆发后,传染病的总体发病率和死亡率立即下降。在大流行控制措施结束后,其发病率急剧上升,死亡率也有所上升。